In the 41-patient REDWOOD-HCM trial, myosin inhibitor CK-274 achieved statistically significant improvements in blood flow reaching the normal range in 13 out of 14 patients with obstructive HCM ...
Her expertise in both traditional HCM processes and modern Redwood implementations positions her as a leader in HR technology innovation. Q1: How do you approach complex HCM implementations?